FORUS Therapeutics
  • About
    • About FORUS
    • Leadership
    • Values
  • Products
  • Partners
  • Careers
  • News
  • Contact
  • Français
Select Page
FORUS Therapeutics will be presenting at the Bloom Burton & Co. Healthcare Investor Conference on May 3rd, 2022

FORUS Therapeutics will be presenting at the Bloom Burton & Co. Healthcare Investor Conference on May 3rd, 2022

Apr 18, 2022

(TORONTO, Ontario) May 2-3, 2022 ­– FORUS Therapeutics Inc, a Canadian Life Sciences company specialized in developing and commercializing unique and differentiated oncology focused therapies is proud to be participating and presenting at the 2022 Bloom Burton &...

Recent Posts

  • US-authorized BESREMi® Now Available
  • FORUS and PharmaEssentia Have Entered Into an Exclusive Licensing Agreement for The Registration and Distribution of BESREMi® for The Treatment of polycythemia vera (PV), in Canada
  • WELCOME, Karen Winkworth
  • WELCOME, Chris Mitton
  • INESSS Recommendation to Deny Reimbursement for Multiple Myeloma Treatment is a Global Outlier

Recent Comments

    Archives

    • March 2025
    • November 2024
    • September 2024
    • April 2024
    • November 2023
    • October 2023
    • September 2023
    • June 2023
    • May 2023
    • April 2023
    • January 2023
    • October 2022
    • September 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • February 2022
    • December 2021
    • September 2021
    • July 2021
    • June 2021
    • January 2021

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Follow

    Privacy   |   Accessibility

    About FORUS
    Leadership
    Values
    Products
    Careers
    Partners
    News
    Contact

    Copyright © 2025 FORUS Therapeutics Inc.
    All rights reserved
    Website Design by Eggbeater Creative.

    Contact Us
    Font Resize
    Accessibility by WAH